Detalles de la búsqueda
1.
Rare coding variants in 35 genes associate with circulating lipid levels-A multi-ancestry analysis of 170,000 exomes.
Am J Hum Genet
; 109(1): 81-96, 2022 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34932938
2.
Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls.
Nature
; 570(7759): 71-76, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31118516
3.
The impact of increased hepatic glucose production caused by empagliflozin on plasma glucose concentration in individuals with type 2 diabetes and nondiabetic individuals.
Diabetes Obes Metab
; 26(3): 1033-1039, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38131252
4.
Unexplained Residual Risk In Type 2 Diabetes: How Big Is The Problem?
Curr Cardiol Rep
; 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38634964
5.
Plasma insulin is required for the increase in plasma angiopoietin-like protein 8 in response to nutrient ingestion.
Diabetes Metab Res Rev
; 39(6): e3643, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36988137
6.
Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes.
Diabetes Obes Metab
; 25(2): 426-434, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36204991
7.
FGF21 contributes to metabolic improvements elicited by combination therapy with exenatide and pioglitazone in patients with type 2 diabetes.
Am J Physiol Endocrinol Metab
; 323(2): E123-E132, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35723225
8.
Modifying chronic kidney disease progression with the mineralocorticoid receptor antagonist finerenone in patients with type 2 diabetes.
Diabetes Obes Metab
; 24(7): 1197-1205, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35302284
9.
Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT).
Diabetes Obes Metab
; 24(5): 899-907, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35014145
10.
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.
Endocr Pract
; 28(10): 923-1049, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35963508
11.
Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects.
Int J Mol Sci
; 23(16)2022 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36012132
12.
Ultrasound-Targeted Microbubble Destruction Mediates Gene Transfection for Beta-Cell Regeneration and Glucose Regulation.
Small
; 17(31): e2008177, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34185956
13.
From glucose lowering agents to disease/diabetes modifying drugs: a "SIMPLE" approach for the treatment of type 2 diabetes.
Cardiovasc Diabetol
; 20(1): 92, 2021 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33910583
14.
Culture on a native bone marrow-derived extracellular matrix restores the pancreatic islet basement membrane, preserves islet function, and attenuates islet immunogenicity.
FASEB J
; 34(6): 8044-8056, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32307751
15.
Using the Schmahmann Syndrome Scale to Assess Cognitive Impairment in Young Adults with Metabolic Syndrome: a Hypothesis-Generating Report.
Cerebellum
; 20(2): 295-299, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33159660
16.
Insulin secretion is a strong predictor for need of insulin therapy in patients with new-onset diabetes and HbA1c of more than 10%: A post hoc analysis of the EDICT study.
Diabetes Obes Metab
; 23(7): 1631-1639, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33852204
17.
Sodium-Glucose Cotransporter 2 Inhibitors and the Kidney.
Diabetes Spectr
; 34(3): 225-234, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34511848
18.
Combination therapy with pioglitazone/exenatide improves beta-cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A 3-year follow-up of the Qatar study.
Diabetes Obes Metab
; 22(12): 2287-2294, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32729222
19.
Hormone-substrate changes with exenatide plus dapagliflozin versus each drug alone: The randomized, active-controlled DURATION-8 study.
Diabetes Obes Metab
; 22(1): 99-106, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31469220
20.
Genetic and environmental (physical fitness and sedentary activity) interaction effects on cardiometabolic risk factors in Mexican American children and adolescents.
Genet Epidemiol
; 42(4): 378-393, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29460292